Sandu Pharmaceuticals Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

38.00 -1.00 (-2.56%)Updated : 17 Dec 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	55.72	52.41	54.17	49.28
Cash Equivalents	1.30	1.00	2.28	0.94
Common Stock Total	9.66	9.66	9.66	8.81
Other Current Assets Total	4.74	3.98	4.13	4.21
Total Assets	55.72	52.41	54.17	49.28
Current Portof LT Debt/ Capital Leases	0.06	0.00	-	-
Total Equity	42.02	40.59	39.24	36.47
Long Term Investments	11.27	12.23	11.58	9.15
Retained Earnings( Accumulated Deficit)	32.36	30.93	29.58	27.66
Total Common Shares Outstanding	0.97	0.97	0.97	0.88
Tangible Book Valueper Share Common Eq	43.47	41.98	40.57	41.36
Total Liabilities	13.70	11.82	14.93	12.81
Total Debt	0.48	0.06	0.00	0.00
Short Term Investments	1.35	0.20	0.02	3.23
Cashand Short Term Investments	2.65	1.21	2.30	4.17
Total Receivables Net	4.76	4.87	4.79	3.99
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Deferred Income Tax	1.20	1.12	1.04	0.94
Accounts Receivable- Trade Net	4.76	4.87	4.79	3.99
Property/ Plant/ Equipment Total- Net	18.12	17.84	16.99	16.45
Total Current Liabilities	12.09	10.64	13.88	11.87
Total Inventory	14.15	12.25	14.33	11.27
Accounts Payable	4.49	4.20	8.40	6.82
Other Currentliabilities Total	7.54	6.44	5.49	5.06
Total Long Term Debt	0.42	0.06	0.00	0.00
Intangibles Net	0.02	0.03	0.05	0.03
Other Long Term Assets Total	0.00	0.00	0.00	0.00
period Length	0.00	0.00	0.00	0.00
Total Current Assets	26.30	22.30	25.54	23.65
Capital Lease Obligations	0.42	0.06	-	-
Other Equity Total	-	-	0.00	0.00